NOX
Click for more information
2.94% 6.6¢ noxopharm limited

Ann: Veyonda Showing Potential to Prevent Cytokine Storm, page-30

  1. quartzhands
    148 Posts.
    lightbulb Created with Sketch. 32
    clock Created with Sketch.
    22/04/21
    22:58
    Post #: 52664684
    These results sound potentially very encouraging.

    My question (I’m not sure if it is possible for it to be answered yet) is probably the million dollar question:
    Is Veyonda more effective than already established methods of regulating pro-inflammatory cytokines?

    For example, Remdesivir + Vitamin D, and corticosteroids (dexamethasone) are already accessible and have been shown to aid regulation of IL-6 in SARS-CoV-2 patients.
    NOX Price at posting: 65.0¢ Sentiment: Hold Disclosure: Not Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.6¢ 		Change
-0.002(2.94%) 		Mkt cap ! $19.28M
Open High Low Value Volume
6.7¢ 6.9¢ 6.6¢ $13.31K 198.1K

Buyers (Bids)

No. Vol. Price($)
1 1137 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.7¢ 22400 1
View Market Depth
Last trade - 15.50pm 28/06/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.